Akèy › Gout
Etid klinik pou Gout ap rekrite nan Etazini
11 etid pou Gout ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Miami, FL4 etid
- Sterling Heights, MI3 etid
- Houston, TX3 etid
- Birmingham, AL3 etid
- Deltona, FL3 etid
- Hialeah, FL3 etid
- Tampa, FL3 etid
- El Cajon, CA3 etid
- Glendale, AZ3 etid
- Boston, MA3 etid
Pa eta
- Alabama4 etid
- Arizona5 etid
- Florid4 etid
- Georgia5 etid
- Illinois4 etid
- Kalifòni6 etid
- Maryland3 etid
- Massachusetts4 etid
- Michigan3 etid
- New York3 etid
- North Carolina4 etid
- South Carolina3 etid
- Texas5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07280156A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07535034A Study of Dotinurad Versus Allopurinol in Participants With Gout
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07089875SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Aug 5, 2026 · NCT06674109Drug-Drug Interaction Study of ABP-671 in Gout Patients
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Apr 14, 2026 · NCT07367971Dose Response of Exercise for Arthritis Management
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT06880653Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT05658575Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
Ap rekriteFaz 4
Laj 18 a 90 · Tout sèks · Mizajou Jan 20, 2026 · NCT07346079Improving Gout Care After an ED Visit
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Jan 16, 2026 · NCT06534554Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Dec 8, 2025 · NCT07145229Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Ap rekriteFaz 4
Laj 18 a 90 · Tout sèks · Mizajou Sep 25, 2025 · NCT04875702Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.